FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 02, 2021 USD ($)	Sep. 30, 2025 USD ($) shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2025 USD ($) shares	Sep. 30, 2024 USD ($) shares	Dec. 31, 2024 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2025 $ / shares	Apr. 06, 2023 USD ($) $ / shares shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Gain (loss) on fair value of financial instruments		$ (1,200)	$ 1,422	$ (2,869)	$ 702
Investment in unconsolidated entity		9,300		9,300		$ 10,800
Derivative asset		590		590		1,075
Derivative liability, noncurrent		1,651		1,651		786
Purchase option	$ 8,000						$ 8,000
Purchase option, term							5 years
Extension, term							2 years
Percentage of outstanding shares							10.00%
Warrants expiration period							60 days
Gain (loss) on change in fair value of purchase option			(375)	(52)	(1,360)
Debt Conversion Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments		(1,001)	1,338	(839)	1,558
Derivative liability, noncurrent		1,651		1,651		786
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated entity		9,300		9,300		10,800
Derivative liability, noncurrent		0		0		0
Financial asset, purchase option						52
Debt Interest Rate Conversion Feature
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments		101	$ 259	(477)	$ 105
Debt interest rate conversion feature
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset		590		590		1,023
Debt interest rate conversion feature | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset		590		590		1,023
BAT Group | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage										1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Principal amount		$ 62,300		$ 62,300		58,172				$ 56,800	$ 75.3
Convertible ownership percentage		19.90%		19.90%
Conversion price (in CAD per share) | $ / shares								$ 2.00
BAT Group | Convertible Notes Payable | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage										5.00%	5.00%
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage		50.00%		50.00%
British American Tobacco | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units ownership percentage		100.00%		100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage		50.00%		50.00%
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Common units (in shares) | shares		4,000,000	400,000	4,000,000	400,000
Gain (loss) on fair value of financial instruments		$ (300)	$ 200	$ (1,500)	$ 400
Investment in unconsolidated entity		$ 9,300		$ 9,300		10,800
DeFloria, LLC | Class A Common Stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding (in shares) | shares									865,052
Warrants exercise price (in USD per share) | $ / shares									$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units (in shares) | shares			200,000		200,000				2,000,000
Capital contributed									$ 10,000
Payment for convertible debt						5,000
DeFloria, LLC | AJNA Biosciences
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Payment for convertible debt						$ 2,000
Common units (in shares) | shares		4,000,000	400,000	4,000,000	400,000